Sales rise 35.51% to Rs 162.21 crore
Net profit of Windlas Biotech rose 64.31% to Rs 15.10 crore in the quarter ended December 2023 as against Rs 9.19 crore during the previous quarter ended December 2022. Sales rose 35.51% to Rs 162.21 crore in the quarter ended December 2023 as against Rs 119.70 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales162.21119.70 36 OPM %12.5411.65 -PBDT23.2015.95 45 PBT19.8112.82 55 NP15.109.19 64Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
